Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded
- Contract number
- SPE2DR26F9AV8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,382
Award facts
- Contract value 100% obligated
- $14,382.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,382.29 to AmerisourceBergen Drug Corp for Actemra ActPen (tocilizumab) 162 mg/0.9 mL auto-injectors. This firm fixed-price delivery order, issued on November 7, 2025, with completion targeted for November 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitive award.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. Actemra (tocilizumab) is a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, representing the type of specialized pharmaceutical products within the company's extensive federal contract portfolio. The DLA's medical supply chain utilizes AmerisourceBergen's prime vendor status to efficiently fulfill pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems on a global basis.
Quick answers
Who was awarded contract SPE2DR26F9AV8?
SPE2DR26F9AV8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26F9AV8 worth?
The government has obligated $14,382 on SPE2DR26F9AV8.
Is contract SPE2DR26F9AV8 an order under another contract?
Yes. SPE2DR26F9AV8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AV8 competed?
The extent of competition for SPE2DR26F9AV8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award